Hungarian real-world research study confirms tolerability of palbociclib similar to registration trials in breast cancer patients. CONTEXT: A retrospective review of 962 Hungarian breast cancer patients published in OncoTargets and Continue Reading
Prospective observational study of clozapine in the treatment of schizophrenia. CONTEXT: 189 patients were included in this 5-year prospective observational study which looked at the safety and tolerability profile when Continue Reading
Real-world evidence paper highlighting the impact of changes to tuberculosis diagnosis and treatment in China CONTEXT: China has managed to reduce the incidence rate of tuberculosis (TB) over the last Continue Reading
Symdeko (tezacaftor/ivacaftor) shows favourable results in Scottish real-world evidence study in cystic fibrosis CONTEXT: Publication of a real-world research study in cystic fibrosis in the European Journal of Hospital Pharmacy Continue Reading
First data from EMPRISE Real-World Evidence study in type 2 diabetes reveals risk reduction for patient on Empagliflozin compared to DPP-4 inhibitors CONTEXT: Interim analysis of the EMPRISE real-world evidence Continue Reading
Medidata’s Acorn AI Synthetic Control Arm (SCA) awarded Best AI-based Solution for Healthcare. CONTEXT: Medidata’s Acorn AI Synthetic Control Arm (SCA) takes Best AI-based Solution for Healthcare at this years Continue Reading
Two Real-World Evidence studies show effectiveness of FDA authorised COVID vaccines CONTEXT: The publication of two peer-reviewed studies from nference (yes that is their name – not a typo) in Continue Reading
Peer reviewed publication of a retrospective real-world evidence study in Type 2 diabetes CONTEXT: A retrospective chart review of type 2 diabetes patients in India receiving either Metformin alone or Continue Reading
Big Data just got bigger as HealthVerity set to grow real-world data platform CONTEXT: Commercial announcement by HealthVerity as they close their series D funding round adding $100million to directly fund the Continue Reading
Goldman Sachs invest $230M in CRO on the back of the decentralised trials craze CONTEXT: Goldman Sachs joins the decentralised trial Gold rush to invest in the contract clinical research Continue Reading
